A detailed history of Seneca House Advisors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Seneca House Advisors holds 4,266 shares of BMY stock, worth $226,908. This represents 0.1% of its overall portfolio holdings.

Number of Shares
4,266
Holding current value
$226,908
% of portfolio
0.1%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$39.66 - $51.75 $169,189 - $220,765
4,266 New
4,266 $220,000
Q1 2024

Apr 17, 2024

SELL
$47.98 - $54.4 $1,679 - $1,904
-35 Reduced 0.83%
4,165 $225,000
Q4 2023

Jan 09, 2024

SELL
$48.48 - $57.85 $10,762 - $12,842
-222 Reduced 5.02%
4,200 $215,000
Q3 2023

Oct 13, 2023

BUY
$57.89 - $64.73 $3,473 - $3,883
60 Added 1.38%
4,422 $256,000
Q2 2023

Jul 20, 2023

SELL
$63.71 - $70.74 $7,008 - $7,781
-110 Reduced 2.46%
4,362 $278,000
Q1 2023

Apr 11, 2023

BUY
$65.71 - $74.53 $197 - $223
3 Added 0.07%
4,472 $309,000
Q4 2022

Jan 30, 2023

BUY
$68.48 - $81.09 $68,685 - $81,333
1,003 Added 28.94%
4,469 $321,000
Q3 2022

Oct 07, 2022

BUY
$0.13 - $76.84 $0 - $230
3 Added 0.09%
3,466 $246,000
Q2 2022

Aug 03, 2022

BUY
$72.62 - $79.98 $21,640 - $23,834
298 Added 9.42%
3,463 $267,000
Q1 2022

Apr 14, 2022

BUY
$61.48 - $73.72 $194,584 - $233,323
3,165 New
3,165 $231,000
Q3 2021

Oct 14, 2021

SELL
$59.17 - $69.31 $186,681 - $218,673
-3,155 Closed
0 $0
Q2 2021

Jul 29, 2021

SELL
$61.91 - $67.42 $866 - $943
-14 Reduced 0.44%
3,155 $211,000
Q1 2021

Apr 27, 2021

SELL
$59.34 - $66.74 $12,936 - $14,549
-218 Reduced 6.44%
3,169 $200,000
Q4 2020

Jan 19, 2021

SELL
$57.74 - $65.43 $30,140 - $34,154
-522 Reduced 13.35%
3,387 $210,000
Q3 2020

Nov 10, 2020

SELL
$57.43 - $63.64 $14,185 - $15,719
-247 Reduced 5.94%
3,909 $236,000
Q2 2020

Aug 12, 2020

BUY
$54.82 - $64.09 $1,589 - $1,858
29 Added 0.7%
4,156 $244,000
Q1 2020

Apr 09, 2020

SELL
$46.4 - $67.43 $15,404 - $22,386
-332 Reduced 7.45%
4,127 $230,000
Q4 2019

Jan 13, 2020

BUY
$49.21 - $64.19 $49 - $64
1 Added 0.02%
4,459 $286,000
Q3 2019

Oct 15, 2019

SELL
$42.77 - $50.71 $40,075 - $47,515
-937 Reduced 17.37%
4,458 $226,000
Q2 2019

Jul 23, 2019

SELL
$44.62 - $49.34 $10,262 - $11,348
-230 Reduced 4.09%
5,395 $238,000
Q1 2019

Apr 22, 2019

BUY
$45.12 - $53.8 $20,078 - $23,941
445 Added 8.59%
5,625 $268,000
Q4 2018

Jan 14, 2019

BUY
$48.76 - $63.23 $6,875 - $8,915
141 Added 2.8%
5,180 $269,000
Q3 2018

Oct 19, 2018

SELL
$55.19 - $62.25 $13,907 - $15,687
-252 Reduced 4.76%
5,039 $313,000
Q2 2018

Jul 23, 2018

SELL
$50.53 - $62.98 $85,901 - $107,066
-1,700 Reduced 24.32%
5,291 $293,000
Q1 2018

Apr 12, 2018

SELL
$59.92 - $68.98 $18,754 - $21,590
-313 Reduced 4.29%
6,991 $442,000
Q4 2017

Feb 20, 2018

BUY
$59.94 - $65.35 $437,801 - $477,316
7,304
7,304 $448,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Seneca House Advisors Portfolio

Follow Seneca House Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seneca House Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Seneca House Advisors with notifications on news.